Resist Alzheimer’s Project

Our report of the 2nd case with extreme protection against autosomal dominant #Alzheimers is out in @NatureMedicine 🧠Check it out! #Reelin #COLBOS @neuroudea @DrJoeArboleda @diegosflab @ytquiroz nature.com/articles/s4159…

🙌 @DesignDataPIA & @ReservePIA offer you a unique "#Resilience in #CognitiveAging" Webinar Series! Join us if you can 😎 Registration DEC 6 👉 tinyurl.com/3z8x9f4e DEC 11 👉 tinyurl.com/y7wmdw6y @ytquiroz @ERogalskiPhD @RoreBole @ArenazaEider @DrAnaCapuano @DBartres_Faz

We are hiring for a tenure-track faculty position at @SinaiBrain! Looking for a computational/systems neuroscientist to join our outstanding Neuroscience Department at Mount Sinai. Open to all levels. Reach out to SinaiNeuroSearch@mssm.edu with any questions. Come work with us!

Education can act as a powerful "cognitive reserve" in mitigating genetic risks for Alzheimer's. Higher education slowed cognitive decline even among those carrying high-risk mutations. neurosciencenews.com/education-gene… #neuroscience 1/2

A Colombian man is only the second patient identified with the miraculous ability to defy the devastating Alzheimer’s gene, an international team of scientists report in the journal Nature Medicine. Doctors hope the two known cases will allow researchers to develop new treatments to protect other people with Alzheimer’s disease. wapo.st/3Oa6FY8

Variantes del gen PSEN1 están relacionadas con la enf. Alzhéimer. No obstante, se han identificado variantes protectoras en los genes APOE y RELN que "anularían" la predisposición a Alzhéimer marcada por PSEN1 y evitarían el desarrollo de la enfermedad. genotipia.com/genetica_medic…

Nuevo hallazgo del GNA y otros investigadores abre puerta para la prevención y tratamiento de enfermedades neurodegenerativas. nature.com/articles/s4159… #orgulloGNA #Alzheimer #Neurociencias

Researchers from @MGHNeurology, @MGHPsychiatry and colleagues find that an Alzheimer’s-defying brain offers clues to treatment and prevention of dementia, in a @SpringerPub study. pubmed.ncbi.nlm.nih.gov/35838824/

📢 Our paper with the neuropath and cellular profiles of the #APOE3 #Christchurch case is now out! 👍🏼 Congrats to co-first authors @diegosflab & @sanchez_js1 #COLBOS #ResistAlz ⁦@neuroudea⁩ ⁦@MGHmapp⁩ ⁦@ytquiroz⁩ link.springer.com/article/10.100…

We just received IRB approval for the new “Healthy Aging & Resilient Brain Study”👍🏼 We’ll be examining protective factors in multicultural individuals over the age of 80 (a.k.a super agers). Study will be available in English/Spanish/Portuguese 😊@MGHmapp @ytquiroz #ENDALZ

Dr. Marino will be presenting some of our most recent work with antibodies that were developed based on our findings with the Colombian patient with the APOE Christchurch mutation! 👍🏼 @MGHmapp #apoemtg2021 @ApoEdscvr

In a longitudinal PET study, Smith et al. show that tau accumulation rates are higher in females, younger Aβ-positive individuals, and those with higher baseline tau load. bit.ly/3qlwLJy

Introducing our new logo! 😍 #ResistAlz #COLBOS #ENDALZ

.@ISTAART @SENDCon2020 #jobposting

Please RT: We’re looking for postdoctoral research fellows to help us advance our work on rare genetic variants that may protect against dementia!! 👍🏼@ytquiroz @MGH_RI @MGHmapp @MGHMartinos @harvardbrainsci @harvardmed @SfNtweets @OHBM @ISTAART #ENDALZ neurojobs.sfn.org/job/27153/post…